Application and Notification of a Performance Study under the EU IVDR: Required Documents 
The MDCG 2022-19 was published on December 2022. This document indicates a series of templates that should be used for performance study applications under the IVDR, while the respective EUDAMED module is not fully functional.

Application for performance studies 

According to IVDR Article 66, to apply for a performance study, the sponsor must submit an application to the Member State(s) in which the study is to be conducted, accompanied by the following documentation: 

  • Application form 
  • Investigator’s brochure 
  • Performance study plan 
  • A signed statement by the manufacturer indicating that the device conforms to the general safety and performance requirements apart from the aspects covered by the study 
  • A copy of the opinion of the ethics committee 
  • Proof of insurance or indemnification in case of injury 
  • Documents used to obtain informed consent 
  • Description of the arrangements on data protection and confidentiality 
  • Available technical documentation 

The IVDR states that the application must be submitted through EUDAMED. However, in the absence of the platform, a series of performance study application documents have been created. 

MDCG 2022-19 

On December 2022, it was published the MDCG 2022-19 related to the performance study application documents under the IVDR. 

These documents are annexed to the MDCG document and include:  

  • Performance study – application form under the IVDR
  • Addendum to the performance study application form for:  
  • Additional device(s)
  • Additional comparator
  • Additional site(s)
  • Performance study support documents – Documents to attach
  • Checklist of general safety and performance requirements, standards, common specifications and scientific opinions

These templates will be withdrawn once the EUDAMED module for performance studies is fully functional. 

Performance study identification numbers 

In the absence of EUDAMED, the Union-wide unique single identification number for a performance study, will be the CIV-ID which can be generated in EUDAMED2, the platform developed to support the old Directives. 

further
reading

cosmetic products

P-Cymene may soon be banned from cosmetics

Ingredient: P-CYMENE

Date of publication: 10/1/2025

P-cymene may be banned from cosmetics as its proposed classification as Reprotoxic 1B is under review and is expected to be approved.

Read More »
cosmetic products

SCCS Preliminary Opinion on Benzophenone-1 (BP-1)

Ingredient: BENZOPHENONE-1

Date of publication: 25/10/2024

On October 25 2024, the Scientific Committee on Consumer Safety (SCCS) could not conclude on the safety of UV absorber Benzophenone-1 (BP-1) due to insufficient data. The deadline for comments is set to January 13, 2025.

Read More »
cosmetic products

UK – OPSS Releases Statuatory Instrument on CMR Substances and Kojic Acid

Ingredients: CMR SUBSTANCES AND KOJIC ACID

Date of publication: 17/12/2024

On December 17, 2024, UK’s Office for Product Safety and Standards (OPSS) published the Cosmetic Products (Restriction of Chemical Substances) (No.2) Regulations 2024′ adding 64 substances classified as Carcinogenic, Mutagenic, or Reprotoxic (CMR) to Annex II of the UK Cosmetics Regulation (UKCR) and Kojic Acid to Annex III of the UKCR.

Read More »
cosmetic products

SCCS Preliminary Opinion on Ethylhexyl Methoxycinnamate (EHMC)

Ingredient: ETHYLHEXYL METHOXYCINNAMATE (EHMC)

Date of publication: 25/10/2024

On October 25 2024, the Scientific Committee on Consumer Safety (SCCS) could not conclude on the safety of UV-filter Ethylhexyl Methocycinnamate (EHMC) due to insufficient data. The deadline for comments is set to January 17, 2025.

Read More »